Why I would buy ResMed and these quality blue chips now

I think these blue chips are best buys and worth considering this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Markets do not always move in straight lines.

Even high-quality businesses can see their share prices drift lower during periods of uncertainty. For long-term investors, those moments can create opportunities to accumulate blue chip ASX shares at more attractive levels.

Here are three quality names I would be comfortable buying now.

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.

Image source: Getty Images

ResMed Inc. (ASX: RMD)

The first blue chip ASX share I would consider buying is ResMed.

ResMed is a global leader in sleep disorder treatments. Its devices and cloud-connected software help millions of patients manage conditions such as sleep apnoea and chronic obstructive pulmonary disease.

But the company is still only scratching at the surface of its market opportunity. Management estimates that there are over 1 billion sufferers of sleep apnoea globally. However, the majority of these people don't know they have the condition.

As awareness grows, ResMed stands to benefit greatly as the clear market leader.

In addition, the company has been investing in digital health platforms that link devices to data, improving patient outcomes and strengthening recurring revenue streams. Combined, this blue chip appears well-placed to continue its growth over the next decade and beyond.

Macquarie Group Ltd (ASX: MQG)

Another blue chip ASX share worth a look is Macquarie Group.

Macquarie has built a global reputation in infrastructure, asset management, and specialist financial services. It benefits from exposure to long-term trends such as renewable energy, digital infrastructure, and alternative assets.

Unlike traditional banks, Macquarie's earnings are more diversified across geographies and business lines. This can provide resilience across economic cycles.

With strong capital management and a track record of reinvesting into growth areas, Macquarie remains one of the more dynamic blue-chip names on the ASX.

Wesfarmers Ltd (ASX: WES)

A final blue chip ASX share I would consider this week is Wesfarmers.

It owns businesses such as Bunnings, Kmart, Target, Priceline, Silk Laser, WesCEF, and Officeworks. These are well-known brands with significant scale advantages in their respective markets.

Bunnings in particular has demonstrated pricing power and operational discipline over many years. Meanwhile, Wesfarmers continues to invest in growth areas, including lithium and health, while maintaining a strong balance sheet.

The company's combination of retail leadership, capital allocation discipline, and diversification could make it a reliable long-term holding.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, ResMed, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

This blue-chip ASX 200 stock is up 30% in 2 months

We don't often see gains like this.

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses offer high dividend yields as well as stability.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Which is the best buy, Coles shares or Wesfarmers shares?

Both are high-quality businesses, but valuation makes this comparison much more interesting.

Read more »

Person holding a blue chip.
Blue Chip Shares

2 leading ASX blue-chip shares experts think are buys

Fund managers are optimistic about the outlook for these stocks…

Read more »

Worried woman calculating domestic bills.
Blue Chip Shares

The bull and bear case for CBA and BHP shares

Are these blue-chips worth buying?

Read more »

Man sits smiling at a computer showing graphs.
Blue Chip Shares

The only 3 ASX blue-chip shares I'd buy and hold until 2036

Three ASX stocks built to compound wealth for decades.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Blue Chip Shares

Why I'd buy BHP and CBA shares in July

I think both of these ASX giants still have more to offer long-term investors.

Read more »

A woman nervously crosses her fingers, indicating hope for positive share price movement.
Blue Chip Shares

July is historically one of the best months for ASX shares. Can July FY27 deliver?

The first week of FY27 has already started strongly. Here's whether BHP, CSL, and Goodman can keep it going.

Read more »